• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适度饮酒对非酒精性脂肪性肝病的影响。

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease.

作者信息

Lemmer Peter, Manka Paul, Best Jan, Kahraman Alisan, Kälsch Julia, Vilchez-Vargas Ramiro, Link Alexander, Chiang Hsin, Gerken Guido, Canbay Ali, Bechmann Lars P, Sydor Svenja

机构信息

Department of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, 44892 Bochum, Germany.

Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany.

出版信息

J Clin Med. 2022 Feb 8;11(3):890. doi: 10.3390/jcm11030890.

DOI:10.3390/jcm11030890
PMID:35160340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8836912/
Abstract

Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) have emerged as leading causes of chronic liver diseases worldwide. ALD and NAFLD share several pathophysiological patterns as well as histological features, while clinically, they are distinguished by the amount of alcohol consumed daily. However, NAFLD coexists with moderate alcohol consumption in a growing proportion of the population. Here, we investigated the effects of moderate alcohol consumption on liver injury, lipid metabolism, and gut microbiota in 30 NAFLD-patients. We anonymously assessed drinking habits, applying the AUDIT- and CAGE-questionnaires and compared subgroups of abstainers vs. low to harmful alcohol consumers (AUDIT) and Cage 0-1 vs. Cage 2-4. Patients who did not drink any alcohol had lower levels of γGT, ALT, triglycerides, and total cholesterol. While the abundance of , , , and was higher in the low to harmful alcohol drinking cohort, the abundance of was higher in the abstainers. Our study suggests that even moderate alcohol consumption has an impact on the liver and lipid metabolism, as well as on the composition of gut microbiota.

摘要

酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)已成为全球慢性肝病的主要病因。ALD和NAFLD具有多种病理生理模式以及组织学特征,而在临床上,它们通过每日饮酒量来区分。然而,在越来越多的人群中,NAFLD与适度饮酒并存。在此,我们研究了适度饮酒对30例NAFLD患者肝损伤、脂质代谢和肠道微生物群的影响。我们使用AUDIT问卷和CAGE问卷对饮酒习惯进行了匿名评估,并比较了戒酒者与低度至有害饮酒者亚组(AUDIT)以及Cage 0 - 1与Cage 2 - 4亚组。不饮酒的患者γGT、ALT、甘油三酯和总胆固醇水平较低。虽然在低度至有害饮酒队列中,[此处原文缺失具体菌种名称]、[此处原文缺失具体菌种名称]、[此处原文缺失具体菌种名称]和[此处原文缺失具体菌种名称]的丰度较高,但在戒酒者中,[此处原文缺失具体菌种名称]的丰度较高。我们的研究表明,即使是适度饮酒也会对肝脏、脂质代谢以及肠道微生物群的组成产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/1031c8a80eb4/jcm-11-00890-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/4c0d86b220b8/jcm-11-00890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/44578f6f4f78/jcm-11-00890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/992968ee4efe/jcm-11-00890-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/1031c8a80eb4/jcm-11-00890-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/4c0d86b220b8/jcm-11-00890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/44578f6f4f78/jcm-11-00890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/992968ee4efe/jcm-11-00890-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7f/8836912/1031c8a80eb4/jcm-11-00890-g004.jpg

相似文献

1
Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease.适度饮酒对非酒精性脂肪性肝病的影响。
J Clin Med. 2022 Feb 8;11(3):890. doi: 10.3390/jcm11030890.
2
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.非酒精性脂肪性肝病与酒精性肝病:两个相互交织的实体。
Front Med (Lausanne). 2020 Aug 20;7:448. doi: 10.3389/fmed.2020.00448. eCollection 2020.
3
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.酒精、微生物群、生活方式会影响酒精性和非酒精性器官损伤。
Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7.
4
Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.适量饮酒与非酒精性脂肪性肝病的肝纤维化进展有关,并且与 2 型糖尿病有协同作用。
Metabolism. 2021 Feb;115:154439. doi: 10.1016/j.metabol.2020.154439. Epub 2020 Nov 25.
5
Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.胆汁酸与非酒精性脂肪性肝病患者的特定肠道微生物群、低水平饮酒及肝纤维化相关。
Liver Int. 2020 Jun;40(6):1356-1365. doi: 10.1111/liv.14453. Epub 2020 Apr 24.
6
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.非酒精性脂肪肝中适量饮酒的影响。
Clin Mol Hepatol. 2020 Oct;26(4):662-669. doi: 10.3350/cmh.2020.0163. Epub 2020 Sep 25.
7
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道菌群失调。
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):375-381. doi: 10.1016/S1499-3872(17)60019-5.
8
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).适量饮酒与非酒精性脂肪性肝病(NAFLD)患者中肝脂肪变性的发生率降低有关。
J Hepatol. 2012 Aug;57(2):384-91. doi: 10.1016/j.jhep.2012.03.024. Epub 2012 Apr 17.
9
Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.以蛋鸡为模型研究盲肠微生物群与非酒精性脂肪性肝炎的相互作用。
Poult Sci. 2019 Jun 1;98(6):2509-2521. doi: 10.3382/ps/pey596.
10
Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?非酒精性脂肪性肝病与酒精性肝病:真的有那么不同吗?
Curr Pharm Des. 2020;26(10):1093-1109. doi: 10.2174/1381612826666200122152417.

引用本文的文献

1
Non-Alcoholic Beer Influences Glucose and Lipid Metabolism and Changes Body Composition in Healthy, Young, Male Adults.非酒精啤酒对健康年轻成年男性的葡萄糖和脂质代谢及身体成分有影响。
Nutrients. 2025 May 9;17(10):1625. doi: 10.3390/nu17101625.
2
MetALD: Clinical aspects, pathophysiology and treatment.线粒体酒精性肝病:临床特征、病理生理学及治疗
JHEP Rep. 2024 Nov 2;7(2):101250. doi: 10.1016/j.jhepr.2024.101250. eCollection 2025 Feb.
3
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.肠道微生物群处于肝脏氧化应激与代谢相关脂肪性肝病的交叉点

本文引用的文献

1
Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?非酒精性脂肪性肝病患者饮酒:是,还是否?
Ann Gastroenterol. 2021 Jul-Aug;34(4):476-486. doi: 10.20524/aog.2021.0641. Epub 2021 Jun 3.
2
An Experimental DUAL Model of Advanced Liver Damage.一种晚期肝损伤的实验性双模型。
Hepatol Commun. 2021 Mar 11;5(6):1051-1068. doi: 10.1002/hep4.1698. eCollection 2021 Jun.
3
Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank.
Antioxidants (Basel). 2025 Jan 6;14(1):56. doi: 10.3390/antiox14010056.
4
Alcohol-associated liver disease: Natural history, management and novel targeted therapies.酒精性肝病:自然史、管理与新型靶向治疗
Clin Mol Hepatol. 2025 Feb;31(Suppl):S112-S133. doi: 10.3350/cmh.2024.0709. Epub 2024 Oct 31.
5
Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms.使用机器学习算法预测中国人群中的脂肪肝疾病
Diagnostics (Basel). 2023 Mar 18;13(6):1168. doi: 10.3390/diagnostics13061168.
6
Triglyceride Glucose-Body Mass Index and Risk of Incident Type 2 Diabetes Mellitus in Japanese People With Normal Glycemic Level: A Population-Based Longitudinal Cohort Study.甘油三酯-血糖-体重指数与血糖正常的日本人 2 型糖尿病发病风险:一项基于人群的纵向队列研究。
Front Endocrinol (Lausanne). 2022 Jul 14;13:907973. doi: 10.3389/fendo.2022.907973. eCollection 2022.
7
Silibinin Schiff Base Derivatives Counteract CCl-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities.水飞蓟宾 Schiff 碱衍生物通过增强抗炎和抗凋亡生物活性来对抗 CCl 诱导的急性肝损伤。
Drug Des Devel Ther. 2022 May 16;16:1441-1456. doi: 10.2147/DDDT.S356847. eCollection 2022.
肥胖与饮酒对肝脏疾病相关发病和死亡风险的联合影响:来自英国生物银行的研究结果
Eur J Clin Nutr. 2022 Jan;76(1):74-83. doi: 10.1038/s41430-021-00923-4. Epub 2021 May 31.
4
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
5
Diagnosis and management of secondary causes of steatohepatitis.脂肪性肝炎的继发原因的诊断与治疗。
J Hepatol. 2021 Jun;74(6):1455-1471. doi: 10.1016/j.jhep.2021.01.045. Epub 2021 Feb 10.
6
The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.肠道微生物群作为治疗非酒精性脂肪性肝病和酒精性肝病的治疗靶点。
Biomed Pharmacother. 2021 Mar;135:111235. doi: 10.1016/j.biopha.2021.111235. Epub 2021 Feb 6.
7
In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.在严重酒精性肝炎中,血清角蛋白 18 片段是一种有诊断、预后和治疗指导价值的生物标志物。
Am J Gastroenterol. 2020 Nov;115(11):1857-1868. doi: 10.14309/ajg.0000000000000912.
8
Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH.肠-胰-肝轴作为治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎的靶点。
Int J Mol Sci. 2020 Aug 13;21(16):5820. doi: 10.3390/ijms21165820.
9
Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity.粪便微生物组可区分酒精摄入与酒精性肝炎,但无法区分疾病严重程度。
Hepatology. 2020 Jul;72(1):271-286. doi: 10.1002/hep.31178.
10
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.